CEO and  Fortune 500 Executive with Experience in Developing and Executing Strategies


Pharmaceutical Manufacturing Operations

Outsourcing Strategies

Quality Systems; Compliance Excellence

Operational Transformation

Operational Excellence – Lean Processes

Driving Operational Efficiencies

Building High Performing Teams

Organizational Restructuring

Budgeting and Planning


xCell Strategic Consulting - President

Patheon Pharmaceuticals - Interim CEO

Patheon Pharmaceuticals - President, North America Commercial Operations

Wyeth Pharmaceuticals

SmithKline Beecham


Member, International Leadership Forum of the ISPE

Member, International Society of Pharmaceutical Engineering (ISPE)

Member, Parenteral Drug Association (PDA)


MBA, Philadelphia University

BS, Mechanical Engineering, Villanova University




Peter Bigelow, President 

Peter has held executive leadership roles and provided management consultation within the biopharmaceutical, healthcare and consumer goods industries for over 28 years. His expertise includes global pharmaceutical manufacturing and supply chain operations, outsourcing strategies, quality systems, compliance excellence, building high performance teams, organizational restructuring, and driving operational efficiencies with lean processes.

Peter has been involved in major operational restructuring, has driven significant network wide improvements in Quality, Cost and Customer Service and has turned around underperforming factories.  He has broad capabilities in driving change and managing Manufacturing and Supply Chain Operations.


  • Improved KPI results including a 10% improvement in Customer Service and Quality (RFT) in just nine months for a leading pharmaceutical company
  • Consolidated supplier base by 40% by establishing innovative management structure a large pharmaceutical company
  • Improved serious quality and supply issues by restructuring site and driving Operational Excellence Program while overseeing successful reinspections a leading pharmaceutical company
  • Led 2nd largest global P\pharmaceutical CMO/CRO and oversaw $700 million publicly traded company through leadership transition 
  • Oversaw global manufacturing and supply chain operations for $3.0 billion worldwide consumer healthcare business for major products in US, Canada, Puerto Rico, Europe and China.